The U.S. pharmaceutical industry, a leader in research and development, now faces an important opportunity: expanding into ...
West Pharmaceutical's high-value product mix is expanding, driving margin growth through proprietary. See why I rate WST ...
Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry that look like strong buys right now: Pfizer (NYSE: PFE) and Eli Lilly (NYSE ...
BALLERUP, Denmark--(BUSINESS WIRE)--Today, LEO Pharma A/S announced the sale of a portfolio of four non-core products to Cheplapharm for EUR 300 million. The agreement represents a milestone in the ...
With over 30 years of experience in drug device engineering, Antares Pharma has nurtured its R&D prowess and specialized in creating custom designed drug delivery devices that are tailored to the ...
LONDON--(BUSINESS WIRE)--Infiniti Research is the world's leading independent provider of strategic market intelligence solutions. Our market intelligence services are designed to connect your ...
In a Truth Social post late Thursday, Trump said that any branded or patented pharmaceutical products brought into the U.S.
Princeton-based Sun Pharmaceutical Industries Limited announced the appointment of Jeremy Allen as vice president, corporate ...
US President Donald Trump announced a slew of tariffs on Thursday (US time). “We will be imposing a 100% Tariff on any branded or patented pharmaceutical Product, unless a Company IS BUILDING their ...
VnExpress International on MSN

US postpones tariffs on Singapore pharma products

The United States has delayed imposing tariffs on Singapore's pharmaceutical exports to give companies more time to negotiate ...
After weeks of speculation, President Donald Trump announced the administration’s plan for pharma tariffs and appeared to back down on the threat of significant action against the European Union. In a ...
For many years transporting high-value pharmaceutical products at <-60 degrees C for greater than 96 hours has seemed an insurmountable challenge for pharma and life science, but TOWER’s deep-frozen ...